首页> 中文期刊> 《浙江大学学报(英文版)B辑:生物医学与生物技术》 >Impact of antitumor regimens on the outcomes of cancer patients with COVID-19:a pooled analysis

Impact of antitumor regimens on the outcomes of cancer patients with COVID-19:a pooled analysis

         

摘要

Since the outbreak of coronavirus disease 2019(COVID-19),which is caused by the severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)discovered in December 2019,the disease has emerged as a global pandemic(Shi et al.,2020;World Health Organization,2020).Several studies have shown a higher incidence of COVID-19,as well as related poor outcomes in patients with malignancies as compared with those without them(Liang et al.,2020;Tian et al.,2020).

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号